Heart Septal Defects, Atrial - 11 Studies Found
| Recruiting |
: Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect :
: 2014-03-25 : Device: Transcatheter device closure Closure of atrial sep |
| Recruiting |
: A Prospective Investigation of Pleth Variability Index (PVI) as a Dynamic Parameter of Fluid Responsiveness in Children : Atrial Septal Defect : 2014-10-23 : Procedure: Volume expansion Fluid bolus of 0.9% normal saline 10 mL/kg over 10 minutes |
| Completed |
: Safety and Effectiveness Study of the Solysafe Septal Occluder : Atrial Septal Defects : 2006-07-16 : Device: Device Closure of a Septal Defect |
| Recruiting |
: MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure :
: Device: Figulla Flex Occluder (Occlutech) Interventional closure of the iASD with an Figulla Flex Occlud |
| Recruiting |
: Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography :
: 2016-06-30 :
|
| Terminated |
: ESCAPE Migraine Trial :
: 2005-12-16 :
|
| Recruiting |
: The Effect on EPCs by Successful Cardiac Occlusion Device Implantation :
: Other: Blood samples Blood samples at baseline and 3 timepoints for EPC analysis |
| Recruiting |
: Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure : Thrombosis : 2010-03-08 : Drug: Low molecular weight heparin Low molecular weight he |
| Active, not recruiting |
: Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects : Migraine : 2008-11-26 : Drug: Clopidogrel Patients will be randomized either to aspirin (80 mg/day) or aspirin (80 mg/day) + clo |
| Recruiting |
: Hyperion™ International Registry Trial :
: 2014-08-14 : Device: ASD and PDA closure |